HomePCRX • NASDAQ
add
Pacira Biosciences Inc
Previous close
$30.32
Day range
$29.77 - $30.50
Year range
$25.33 - $41.65
Market cap
1.39B USD
Avg Volume
847.77K
P/E ratio
23.08
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 167.12M | 4.23% |
Operating expense | 102.78M | 2.34% |
Net income | 8.98M | 145.96% |
Net profit margin | 5.37 | 144.09% |
Earnings per share | 0.62 | 16.98% |
EBITDA | 33.54M | 17.20% |
Effective tax rate | 34.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 325.89M | 87.29% |
Total assets | 1.58B | 3.93% |
Total liabilities | 691.16M | -8.50% |
Total equity | 892.16M | — |
Shares outstanding | 46.55M | — |
Price to book | 1.58 | — |
Return on assets | 2.39% | — |
Return on capital | 2.58% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 8.98M | 145.96% |
Cash from operations | 49.10M | 156.70% |
Cash from investing | -15.53M | -123.47% |
Cash from financing | -2.82M | 98.17% |
Net change in cash | 30.75M | 144.83% |
Free cash flow | 46.87M | 505.71% |
About
Founded
2006
Headquarters
Website
Employees
712